Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

Cantor Fitzgerald analyst Imogen Mansfield has initiated coverage on Entera Bio (NASDAQ: ENTX) with an Overweight rating. This marks a significant endorsement for the company as it seeks to attract investor interest.